Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer

Previous studies suggest beta-adrenergic receptor (β-AR) antagonists (β-blockers) decrease breast cancer progression, tumor metastasis, and patient mortality; however the mechanism for this is unknown. Immunohistochemical analysis of normal and malignant breast tissue revealed overexpression of β1-A...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Montoya, Alexa, Amaya, Clarissa N., Belmont, Andres, Diab, Nabih, Trevino, Richard, Villanueva, Geri, Rains, Steven, Sanchez, Luis A., Badri, Nabeel, Otoukesh, Salman, Khammanivong, Ali, Liss, Danielle, Baca, Sarah T., Aguilera, Renato J., Dickerson, Erin B., Torabi, Alireza, Dwivedi, Alok K., Abbas, Aamer, Chambers, Karinn, Bryan, Brad A., Nahleh, Zeina
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2016
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351644/
https://ncbi.nlm.nih.gov/pubmed/28031536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14119
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍